Irinotecan Single-Drug Treatment For Children With Refractory or Recurrent Hepatoblastoma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Irinotecan (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 17 Sep 2013 Biomarkers information updated
- 10 Oct 2009 New source identified and integrated (United Kingdom Clinical Research Network; 1377).
- 07 Jul 2009 Planned end date changed from 8 Oct 2006 to 8 Dec 2008 as reported by ClinicalTrials.gov.